Antioxidants and Cognitive-Behavioral Therapy in Patients with Functional Dyspepsia

Аim: development of an algorithm for the use of antioxidant cognitive-behavioral therapy in adult patients with functional dyspepsia.

Material and methods. The study included 112 adult patients with functional dyspepsia receiving the antioxidant drug Cytoflavin containing succinic acid, inosine, nicotinamide and riboflavin, and cognitive behavioral therapy according to the method of Beck and Jacobson in addition to the main therapy (prokinetics, proton pump inhibitors, psychotropic drugs).

Results. Of the total group, 74 patients had an optimal response to the inclusion of an antioxidant and psychotherapy in the treatment regimen (increased quality of life and reduced anxiety) and 38 patients had the insignificant response. It has been established that the main predictors of the successful use of an extended treatment regimen are the patient's disadaptation in relation to the disease, a recent stress factor, the duration of functional dyspepsia, the presence of an overlap syndrome (combination with other functional gastrointestinal disorders).

Conclusions. Based on the collection of a small amount of anamnestic information (the duration of functional dyspepsia, the presence of an acute stress factor in the anamnesis), the assessment of the presence of an overlap syndrome and disadaptation in relation to the patient to his illness, the value of the discriminant function is calculated. After comparing it with a threshold, the probability of a positive response to a combination of antioxidant and cognitive-behavioral therapy is estimated. The developed prediction algorithm is valid (sensitivity — 91 %, specificity — 73 %, accuracy — 84.8 %) and allows to optimize the definition of treatment tactics for a patient with functional dyspepsia.

1. Ivashkin V.T., Maev I.V., Lapina T.L., Fedorov E.D., Sheptulin A.A., Trukhmanov A.S., et al. Clinical recommendations of Russian gastroenterological association and RENDO Endoscopic Society on diagnosis and treatment of gastritis and duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(4):70–99 (In Russ.). DOI: 10.22416/1382-4376-2021-31-4-70-99

2. Wauters L., Dickman R., Drug V., Mulak A., Serra J., Enck P., et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. United European Gastroenterol J. 2021;9(3):307–31. DOI: 10.1002/ueg2.12061

3. Miwa H., Nagahara A., Asakawa A., Arai M., Oshima T., Kasugai K., et al. Evidence-based clinical practice guidelines for functional dyspepsia 2021. J Gastroenterol. 2022;57(2):47–61. DOI: 10.1007/s00535-021-01843-7

4. Aziz I., Palsson O.S., Törnblom H., Sperber A.D., Whitehead W.E., Simrén M. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: A cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018;3(4):252–62. DOI: 10.1016/S2468-1253(18)30003-7

5. Koloski N.A., Talley N.J., Boyce P.M. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: A critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001;96(5):1340–9. DOI: 10.1111/j.1572-0241.2001.03789.x

6. Drossman D.A., Hasler W.L. Rome IV – functional GI disorders: Disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–61. DOI: 10.1053/j.gastro.2016.03.035

7. Rodrigues D.M., Motomura D.I., Tripp D.A., Beyak M.J. Are psychological interventions effective in treating functional dyspepsia? A systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36(8):2047–57. DOI: 10.1111/jgh.15566

8. Ivashkin V.T., Mayev I.V., Sheptulin A.A., Lapina T.L., Trukhmanov A.S., Kartavenko I.M., et al. Diagnosis and treatment of the functional dyspepsia: Clinical guidelines of the Russian Gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(1):50–61 (In Russ.). DOI: 10.22416/1382-4376-2017-27-1-50-61

9. Ebik B., Aslan N., Ekin N., Bacaksiz F., Arpa M., Neselioglu S., et al. Oxidative stress and the importance of H. pylori eradication in patients with functional dyspepsia. Saudi J Gastroenterol. 2022;28(6):434–40. DOI: 10.4103/sjg.sjg_114_22

10. Suzuki H., Nishizawa T., Tsugawa H., Mogami S., Hibi T. Roles of oxidative stress in stomach disorders. J Clin Biochem Nutr. 2012;50(1):35–9. DOI: 10.3164/jcbn.11-115SR

11. Sapozhnikova T.V., Parfenov S.A., Elkin A.A., Rizakhanov D.M., Rizakhanova O.A. Effect of cytoflavin on the quality of life of patients with functional dyspepsia. Experimental and Clinical Gastroenterology. 2022;8:133–40 (In Russ.). DOI: 10.31146/1682-8658-ecg-204-8-133-140

12. Zakharov K.I., Belov V.G., Parfenov Yu.A., Parfenov S.A., Ershov E.V., Sapozhnikov K.V., et al. Substantiation of the drug “Cytoflavin” application and cognitive-behavioral therapy in complex treatment of deforming coxarthrosis in elderly patients. Advances in Gerontology. 2019;32(3):439–44 (In Russ.).

13. Parfenov S.A. Therapy of chronic forms of apical periodontitis in old age. Advances in Gerontology. 2013;26(3):553–7 (In Russ.).

14. Parfenov Yu.A., Ilyinsky N.S., Parfenov S.A. The effect of the drug Cytoflavin on the psychophysiological status of patients with alcoholism. Poliklinika. 2016;4–3:39–42 (In Russ.).

15. Belov V.G., Parfenov Yu.A., Vasilevskaya M.A., Parfenov S.A., Kovalenko A.L., Zaplutanov V.A. Evaluation of the effect of BOS therapy and Cytoflavin on the dynamics of clinical and psychophysiological status in elderly patients with osteochondrosis. Advances in Gerontology. 2017;4(30):601–8 (In Russ.).

16. Soo S., Forman D., Delaney B.C., Moayyedi P. A systemic review of psychological therapies for nonulcer duspepsia. Am J Gastroenterol. 2004;99(9):1817–22. DOI: 10.1111/j.1572-0241.2004.30086.x

17. Orive M., Barrio I., Orive V.M., Matellanes B., Padierna J.A., Cabriada J., et al. A randomized controlled trial of a 10 week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia. J Psychosom Res. 2015;78(6):563–8. DOI: 10.1016/j.jpsychores.2015.03.003

18. Turik E.V. Psychocorrective work with patients suffering from chronic back pain. Severo-Kavkazskii psikhologicheskii vestnik — North-Caucasian Psychological Bulletin. 2019;17(1):5–12 (In Russ.).

19. Dobaeva N.V., Kibrik N.D. Psychotherapeutic correction of sexual dysfunctions in persons with chronic dermatoses. Psychiatry, psychotherapy and clinical Psychology. 2020;11(1):206– 12 (In Russ.). DOI: 10.34883/PI.2020.11.1.020

20. Kayasheva O.I. Existential aspects of experiencing the fear of death in patients with multiple sclerosis. Modern science: actual problems of theory and practice. Series: Cognition. 2022;6:47–52 (In Russ.). DOI: 10.37882/2500-3682.2022.06.12

21. Blinova K.A., Pchelintseva E.V., Lapochkina N.P. A clinical case of combined correction of children's traumatic experience and distress in the development of cancer. Research and Practical Medicine Journal. 2020;7(1):75–82 (In Russ.). DOI: 10.17709/2409-2231-2020-7-1-8

22. Gusakova E.V., Pasechnik I.N. A multidisciplinary approach to the treatment of the surgical patient: The role of the physician rehabilitation. Kremlin Medicine Journal. 2019;1:99–104 (In Russ.). DOI: 10.26269/qk3v-8n89

23. Foster J.A., Rinaman L., Cryan J.F. Stress and the gutbrain axis: Regulation by the microbiome. Neurobiol Stress. 2017;19(7):124–36. DOI: 10.1016/j.ynstr.2017.03.001

24. Maes M., Kubera M., Leunis J.C., Berk M., Geffard M., Bosmans E. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand. 2013;127(5):344–54. DOI: 10.1111/j.1600-0447.2012.01908.x

25. Wang Y., Chen Y., Zhang X., Lu Y., Chen H. New insights in intestinal oxidative stress damage and the health intervention effects of nutrients: A review. Journal of Functional Foods. 2020;75:104248. DOI: 10.1016/j.jff.2020.104248